Insider buying last 90 days
No open-market insider purchases were filed for ITGR in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Integer (ITGR) slipped this week after third-quarter 2026 results showed sales declining 3.9% and adjusted diluted earnings per share falling 25.1%, with weaker cardio and vascular sales partly offset by growth in cardiac rhythm management and neuromodulation. Following the report, StoneX analyst Robert Wasserman reiterated a Hold rating on the stock.
Shares closed at $126.56, above both the 50-day average of $126.37 and the 200-day average of $102.03, with the 50-day above the 200-day. The GekkoIndex reads 54.2, placing ITGR in the Neutral zone, down 0.3 over the past five sessions. Price sits 0.9% below Gekko Fair Value of $127.70, within the narrow band Gekko treats as fair pricing.
The next earnings date is 18 February 2027, 100 days out and beyond a typical 20-trading-day holding window, with the last reaction at 3.2% following an EPS beat of $1.60 against a $1.38 estimate. No insider, Congress or unusual options activity appears in the current windows, and billionaire holders stand at zero. Seasonally, the next 20 trading days have averaged a 1.6% gain over 5 years, rising in 3 of those years. The consensus target sits at $127, implying 0.3% upside, worth noting alongside the stock's recent run to a 52-week high of $126.83.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Integer scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
Above 50 and 200-day
Close $126.70 is above the 50-day ($126.47) and 200-day ($102.84) averages, and the 50-day is above the 200-day.
See the chart55, Neutral
Reading 55 is in the Neutral zone.
See the GekkoIndex4.2% above
Price is within 5% of Gekko Fair Value (4.2% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 95 days
Next report Feb 18, 2027, 95 days away — outside a typical 20-trading-day hold.
See earnings+1.9% on average
From this point in the calendar, the next 20 trading days averaged +1.9% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Integer closed at $126.70 on Nov 13, 2026, +82.3% over the past year, inside a 52-week range of $66.51 to $126.83.
Use the left and right arrow keys to read daily values.
Put ITGR on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Integer makes devices and components used in medical procedures on behalf of other manufacturers rather than selling under its own brand to patients or hospitals directly. Its work spans areas such as interventional cardiology, structural heart repair, heart failure treatment, neurovascular and peripheral procedures, oncology, electrophysiology, vascular access, infusion, dialysis, urology and gastroenterology. Among its products are pacemakers, defibrillators, cardiac leads and monitors, spinal cord stimulators, surgical tools for arthroscopic, laparoscopic and general procedures, orthopedic instruments for hip, knee and spine work, and both rechargeable and non-rechargeable battery systems.
The company runs two main divisions. The Medical segment covers the device and component work described above, while the Non-Medical segment builds tailored battery power and management systems for energy, military and environmental uses. Its customers are largely multinational original equipment manufacturers and their subsidiaries, which rely on Integer to support cardiac, neuromodulation, orthopedic, vascular, surgical and portable medical applications.
Integer was established in 1970 and is based in Plano, Texas, with additional operations in the United States, Puerto Rico, Costa Rica and other international locations. Its shares are listed on the NYSE under the ticker ITGR.
Integer’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 55, in the Neutral zone, up 0.7 points over five sessions.
Up 0.7 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 54 | −0.1% | +0.5% | ||
| Accumulation | 169 | +1.0% | +2.4% | ||
| Neutral (current zone) | 451 | +0.1% | +0.7% | ||
| Distribution | 21 | −1.1% | +0.1% | ||
| Selling | 7 | Too few readings yet | |||
Average ITGR share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Integer trades 4.2% above Gekko Fair Value of $121.56, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Integer shares are worth, recalculated every trading day.
$121.56
Gekko Fair Value, Nov 14, 2026
4.2% above fair value · About fair value
At the end of Aug 2026 the price was 6.7% above the estimate.
No open-market insider purchases were filed for Integer, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for ITGR in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in ITGR were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Integer has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold ITGR.
Integer reports on Feb 18, 2027, before the open (95 days away), and beat the EPS estimate in 6 of its last 8 reports.
Feb 18, 2027
Expected before the open, 95 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 3, 2026 | $1.60 est $1.38 | $464.1M est $451.1M | +3.2% |
| Apr 30, 2026 | $1.20 est $1.19 | $439.6M est $426.5M | +0.4% |
| Feb 19, 2026 | $1.76 est $1.70 | $472.1M est $462.7M | −1.9% |
| Oct 23, 2025 | $1.79 est $1.68 | $467.7M est $462.7M | −33.2% |
| Jul 24, 2025 | $1.55 est $1.57 | $476.5M est $466.5M | −6.3% |
| Apr 24, 2025 | $1.31 est $1.27 | $437.4M est $428.7M | +2.4% |
| Feb 20, 2025 | $1.43 est $1.46 | $449.5M est $437.1M | −9.3% |
| Oct 24, 2024 | $1.43 est $1.36 | $431.4M est $447.0M | −0.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Integer is $127.00, +0.2% from the last close.
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Integer averaged +1.9% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.1% | 4 of 5 |
| Next 10 trading days | −0.8% | 3 of 5 |
| Next 15 trading days | −0.7% | 2 of 5 |
| Next 20 trading days | +1.9% | 4 of 5 |
| Next 30 trading days | +3.2% | 2 of 5 |
For scale, ITGR’s typical 20-trading-day move in either direction is about 4.7%.
Integer’s market cap is $4.31B, with a P/E ratio of 42.5 and revenue of $1.83B over the last twelve months.
Integer’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Neutral | 15.0% above |
| ABTAbbott Laboratories | Neutral | 10.5% below |
| DHRDanaher | Neutral | 4.7% above |
| ISRGIntuitive Surgical | Neutral | 17.5% above |
| MDTMedtronic | Neutral | 14.2% below |
| SYKStryker | Neutral | 0.1% below |
A peer links to its own page where one exists.
Integer’s market cap is $4.31B at the Nov 13, 2026 close of $126.70, with 34.00M shares outstanding. The shares trade on a P/E ratio of 42.5.
The consensus analyst 12-month price target for Integer is $127.00, +0.2% from the last close. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Integer is about fair value: the Nov 13, 2026 close of $126.70 is 4.2% above Gekko Fair Value of $121.56. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Integer is expected to report on Feb 18, 2027, before the market opens (95 days away). Analysts expect earnings of $1.60 per share on revenue of $460.9M. Integer beat the earnings estimate in 6 of its last 8 reports, moving 7.2% on average across the report.
Integer’s 52-week high is $126.83 and its 52-week low is $66.51; it closed at $126.70 on Nov 13, 2026, +82.3% over the past year. Over the last five years the shares peaked at $146.36 on Jan 30, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 2 as mixed (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.